FREE CONSULTATION (713) 621-7944

Blog

Viekira Pak a ‘Bad’ Option for Hep C Patients?

January 19, 2016 · FLEMING | NOLEN | JEZ, L.L.P.

In recent studies and analysis, there has been some data suggesting that Viekira Pak, a hep C treatment from AbbVie Inc., may be the least safe option of the available leading treatments. The data also shows that it is associated with roughly $6.5 million in avoidable downstream medical expenses. From January 2015 to October 2015, Advera Health filed seven separate…
read more